# CLDN22

## Overview
The CLDN22 gene encodes claudin 22, a transmembrane protein that is part of the claudin family, which is integral to the formation of tight junctions in epithelial and endothelial cells. These tight junctions are crucial for maintaining cell polarity and regulating paracellular transport, thereby ensuring tissue homeostasis and integrity. Claudin 22, like other claudins, features a structure with four transmembrane helices and is involved in cell adhesion and junction assembly. Although the expression of CLDN22 is relatively restricted, it has been identified in specific tissues, including certain cancer types, suggesting a potential role in pathological conditions. The protein's function in maintaining epithelial and endothelial barriers highlights its importance in cellular and organismal health (LalNag2009The; Hewitt2006The; Alghamdi2023Identification).

## Structure
Claudin 22 (CLDN22) is a member of the claudin family, which are integral membrane proteins characterized by their role in forming tight junctions in epithelial and endothelial cells. The protein structure of claudins, including CLDN22, typically features four transmembrane helices. These helices are connected by two extracellular loops and one intracellular loop, with both the amino and carboxy termini located in the cytoplasm (LalNag2009The). The first extracellular loop contains charged amino acids that influence charge selectivity, while the second loop can form dimers with claudins on opposing cell membranes, contributing to cell-cell adhesion (LalNag2009The).

The carboxy-terminal tail of claudins, including CLDN22, is variable in length and contains a PDZ-domain-binding motif, which facilitates interactions with cytoplasmic scaffolding proteins (LalNag2009The). This structural feature is crucial for the protein's function in tight junctions. Although specific post-translational modifications for CLDN22 are not detailed, claudins in general can undergo modifications such as phosphorylation, which regulate their function and localization (LalNag2009The). The precise molecular structure of CLDN22, including any unique domains or isoforms, is not extensively detailed in the available literature.

## Function
Claudin 22 (CLDN22) is a member of the claudin family, which plays a crucial role in the formation and maintenance of tight junctions in epithelial and endothelial cells. These tight junctions are essential for regulating paracellular transport and maintaining cell polarity, thereby contributing to tissue homeostasis and integrity (Alghamdi2023Identification). CLDN22 is involved in biological processes such as cell adhesion and junction assembly, which are vital for maintaining the structural integrity of tissues (Alghamdi2023Identification).

The expression pattern of CLDN22 is relatively restricted compared to other claudin family members. It has been identified in specific tissues, such as breast cancer and brain astrocytoma libraries, indicating a limited expression pattern in normal tissues (Hewitt2006The). Although the specific function of CLDN22 in healthy human cells is not extensively detailed, its involvement in tight junctions suggests a role in maintaining epithelial and endothelial barriers, which are critical for proper cellular function and organismal health (Alghamdi2023Identification). The protein's activity is likely concentrated at the tight junctions, where it contributes to the regulation of cellular permeability and barrier function.

## Clinical Significance
The clinical significance of the CLDN22 gene, which encodes a member of the claudin family involved in tight junction formation, is not fully understood. However, alterations in its expression have been associated with certain conditions. In the context of obesity, a study found that decreased expression of CLDN22 is correlated with increased body weight in mice. This downregulation is thought to disrupt barrier function, leading to nutrient leakage and absorption, which may contribute to weight gain. The study suggests that manipulating the gut microbiota, specifically the Ruminococcaceae family, could influence CLDN22 expression and potentially inhibit weight gain (Nemoto2022Abundance).

In cancer research, CLDN22 has been identified in a limited number of cancer libraries, including breast cancer and brain astrocytoma, suggesting a potential association with these malignancies (Hewitt2006The). However, the specific role of CLDN22 in cancer pathogenesis remains unclear, and further research is needed to elucidate its involvement in these and other diseases. Overall, while CLDN22 is implicated in certain conditions, the direct causal relationships and mechanisms require additional investigation.


## References


1. (Nemoto2022Abundance) Abundance of Ruminococcaceae is Associated with Claudin 22 Gene Expression and Body Weight in Mice. This article has 0 citations.

[2. (LalNag2009The) Madhu Lal-Nag and Patrice J Morin. The claudins. Genome Biology, 10(8):235, 2009. URL: http://dx.doi.org/10.1186/gb-2009-10-8-235, doi:10.1186/gb-2009-10-8-235. This article has 258 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/gb-2009-10-8-235)

[3. (Hewitt2006The) Kyle J Hewitt, Rachana Agarwal, and Patrice J Morin. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer, July 2006. URL: http://dx.doi.org/10.1186/1471-2407-6-186, doi:10.1186/1471-2407-6-186. This article has 364 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2407-6-186)

[4. (Alghamdi2023Identification) Rana A. Alghamdi and Maryam H. Al-Zahrani. Identification of key claudin genes associated with survival prognosis and diagnosis in colon cancer through integrated bioinformatic analysis. Frontiers in Genetics, September 2023. URL: http://dx.doi.org/10.3389/fgene.2023.1221815, doi:10.3389/fgene.2023.1221815. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2023.1221815)